A Mouse Model of Neurotoxicity Induced by Human CD19-Specific CAR T-cells: CAR T-cells Accumulate in the Subarachnoid Space Prior to Trafficking into the Brain Parenchyma 3807 Article Swipe
Christopher A. Pennell
,
Pei‐Pei Chiang
,
Nina Ineza
,
Bruce R. Blazar
,
Marija Cvetanović
,
Eric A. Newman
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1093/jimmun/vkaf283.1566
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1093/jimmun/vkaf283.1566
Description Immune cell-associated neurotoxicity syndrome (ICANS) is a common morbidity associated with human CD19-specific chimeric antigen receptor T-cell (CAR19) immunotherapy. The etiology of ICANS is not well understood but is thought to involve breakdown of the blood-brain barrier (BBB) and subsequent entry of proinflammatory cytokines and CAR19 cells into the brain parenchyma. To understand how CAR19 therapy leads to ICANS, we developed a human CD19 transgenic (hCD19Tg) mouse model that replicates the anti-tumor efficacy and all reported toxicities – including ICANS - associated with CAR19 clinical therapy. Although the BBB is compromised in our model, it does not appear to be the major entry site of CAR19 cells. Rather, two-photon microscopy reveals that CAR19 cells first accumulate in the subarachnoid space and then migrate down into the parenchyma through perivascular spaces. Co-injected control CAR T-cells also accumulate in the subarachnoid space but do not migrate into the parenchyma, suggesting trafficking is antigen-specific. We are testing the hypotheses that: 1) accumulation of CAR19 cells in the subarachnoid space reflects their localization to the subarachnoid lymphatic-like membrane (SLYM) and 2) their subsequent migration into the parenchyma through the perivasculature is driven via recognition of hCD19 on mural cells. By understanding how CAR19 cells enter the brain, we hope to develop strategies to blunt or prevent ICANS. Funding Sources Supported by NIH/NCI R01 CA263090 Topic Categories Tumor Immunology: Checkpoints, Prevention, and Treatment (TIPT)
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/jimmun/vkaf283.1566
- https://academic.oup.com/jimmunol/article-pdf/214/Supplement_1/vkaf283.1566/65410694/vkaf283.1566.pdf
- OA Status
- bronze
- OpenAlex ID
- https://openalex.org/W4416446728
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4416446728Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/jimmun/vkaf283.1566Digital Object Identifier
- Title
-
A Mouse Model of Neurotoxicity Induced by Human CD19-Specific CAR T-cells: CAR T-cells Accumulate in the Subarachnoid Space Prior to Trafficking into the Brain Parenchyma 3807Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-01Full publication date if available
- Authors
-
Christopher A. Pennell, Pei‐Pei Chiang, Nina Ineza, Bruce R. Blazar, Marija Cvetanović, Eric A. NewmanList of authors in order
- Landing page
-
https://doi.org/10.1093/jimmun/vkaf283.1566Publisher landing page
- PDF URL
-
https://academic.oup.com/jimmunol/article-pdf/214/Supplement_1/vkaf283.1566/65410694/vkaf283.1566.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/jimmunol/article-pdf/214/Supplement_1/vkaf283.1566/65410694/vkaf283.1566.pdfDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W4416446728 |
|---|---|
| doi | https://doi.org/10.1093/jimmun/vkaf283.1566 |
| ids.doi | https://doi.org/10.1093/jimmun/vkaf283.1566 |
| ids.openalex | https://openalex.org/W4416446728 |
| fwci | |
| type | article |
| title | A Mouse Model of Neurotoxicity Induced by Human CD19-Specific CAR T-cells: CAR T-cells Accumulate in the Subarachnoid Space Prior to Trafficking into the Brain Parenchyma 3807 |
| biblio.issue | Supplement_1 |
| biblio.volume | 214 |
| biblio.last_page | |
| biblio.first_page | |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | en |
| locations[0].id | doi:10.1093/jimmun/vkaf283.1566 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S38008053 |
| locations[0].source.issn | 0022-1767, 1550-6606 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0022-1767 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | The Journal of Immunology |
| locations[0].source.host_organization | https://openalex.org/P4320800377 |
| locations[0].source.host_organization_name | American Association of Immunologists |
| locations[0].source.host_organization_lineage | https://openalex.org/P4320800377 |
| locations[0].source.host_organization_lineage_names | American Association of Immunologists |
| locations[0].license | |
| locations[0].pdf_url | https://academic.oup.com/jimmunol/article-pdf/214/Supplement_1/vkaf283.1566/65410694/vkaf283.1566.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | The Journal of Immunology |
| locations[0].landing_page_url | https://doi.org/10.1093/jimmun/vkaf283.1566 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5055928297 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2901-6554 |
| authorships[0].author.display_name | Christopher A. Pennell |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I130238516 |
| authorships[0].affiliations[0].raw_affiliation_string | Masonic Cancer Center, University of Minnesota |
| authorships[0].institutions[0].id | https://openalex.org/I130238516 |
| authorships[0].institutions[0].ror | https://ror.org/017zqws13 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I130238516 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | University of Minnesota |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Christopher A. Pennell |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Masonic Cancer Center, University of Minnesota |
| authorships[1].author.id | https://openalex.org/A5030249612 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Pei‐Pei Chiang |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I130238516, https://openalex.org/I4210101327 |
| authorships[1].affiliations[0].raw_affiliation_string | University of Minnesota, Twin Cities |
| authorships[1].institutions[0].id | https://openalex.org/I4210101327 |
| authorships[1].institutions[0].ror | https://ror.org/01en4s460 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210101327 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Twin Cities Orthopedics |
| authorships[1].institutions[1].id | https://openalex.org/I130238516 |
| authorships[1].institutions[1].ror | https://ror.org/017zqws13 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I130238516 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | University of Minnesota |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Pei-Pei Chiang |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | University of Minnesota, Twin Cities |
| authorships[2].author.id | https://openalex.org/A5120327553 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Nina Ineza |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I130238516 |
| authorships[2].affiliations[0].raw_affiliation_string | Masonic Cancer Center, University of Minnesota |
| authorships[2].institutions[0].id | https://openalex.org/I130238516 |
| authorships[2].institutions[0].ror | https://ror.org/017zqws13 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I130238516 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | University of Minnesota |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Nina Ineza |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Masonic Cancer Center, University of Minnesota |
| authorships[3].author.id | https://openalex.org/A5058268746 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-9608-9841 |
| authorships[3].author.display_name | Bruce R. Blazar |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I130238516 |
| authorships[3].affiliations[0].raw_affiliation_string | Masonic Cancer Center, University of Minnesota |
| authorships[3].institutions[0].id | https://openalex.org/I130238516 |
| authorships[3].institutions[0].ror | https://ror.org/017zqws13 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I130238516 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | University of Minnesota |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Bruce R. Blazar |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Masonic Cancer Center, University of Minnesota |
| authorships[4].author.id | https://openalex.org/A5011963571 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-7744-736X |
| authorships[4].author.display_name | Marija Cvetanović |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I130238516, https://openalex.org/I4210101327 |
| authorships[4].affiliations[0].raw_affiliation_string | University of Minnesota, Twin Cities |
| authorships[4].institutions[0].id | https://openalex.org/I4210101327 |
| authorships[4].institutions[0].ror | https://ror.org/01en4s460 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210101327 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Twin Cities Orthopedics |
| authorships[4].institutions[1].id | https://openalex.org/I130238516 |
| authorships[4].institutions[1].ror | https://ror.org/017zqws13 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I130238516 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | University of Minnesota |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Marija Cvetanovic |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | University of Minnesota, Twin Cities |
| authorships[5].author.id | https://openalex.org/A5059251827 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-9296-6237 |
| authorships[5].author.display_name | Eric A. Newman |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I130238516, https://openalex.org/I4210101327 |
| authorships[5].affiliations[0].raw_affiliation_string | University of Minnesota, Twin Cities |
| authorships[5].institutions[0].id | https://openalex.org/I4210101327 |
| authorships[5].institutions[0].ror | https://ror.org/01en4s460 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210101327 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Twin Cities Orthopedics |
| authorships[5].institutions[1].id | https://openalex.org/I130238516 |
| authorships[5].institutions[1].ror | https://ror.org/017zqws13 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I130238516 |
| authorships[5].institutions[1].country_code | US |
| authorships[5].institutions[1].display_name | University of Minnesota |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Eric Newman |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | University of Minnesota, Twin Cities |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/jimmunol/article-pdf/214/Supplement_1/vkaf283.1566/65410694/vkaf283.1566.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-23T00:00:00 |
| display_name | A Mouse Model of Neurotoxicity Induced by Human CD19-Specific CAR T-cells: CAR T-cells Accumulate in the Subarachnoid Space Prior to Trafficking into the Brain Parenchyma 3807 |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-28T14:20:52.410454 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1093/jimmun/vkaf283.1566 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S38008053 |
| best_oa_location.source.issn | 0022-1767, 1550-6606 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0022-1767 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | The Journal of Immunology |
| best_oa_location.source.host_organization | https://openalex.org/P4320800377 |
| best_oa_location.source.host_organization_name | American Association of Immunologists |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4320800377 |
| best_oa_location.source.host_organization_lineage_names | American Association of Immunologists |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://academic.oup.com/jimmunol/article-pdf/214/Supplement_1/vkaf283.1566/65410694/vkaf283.1566.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | The Journal of Immunology |
| best_oa_location.landing_page_url | https://doi.org/10.1093/jimmun/vkaf283.1566 |
| primary_location.id | doi:10.1093/jimmun/vkaf283.1566 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S38008053 |
| primary_location.source.issn | 0022-1767, 1550-6606 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0022-1767 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | The Journal of Immunology |
| primary_location.source.host_organization | https://openalex.org/P4320800377 |
| primary_location.source.host_organization_name | American Association of Immunologists |
| primary_location.source.host_organization_lineage | https://openalex.org/P4320800377 |
| primary_location.source.host_organization_lineage_names | American Association of Immunologists |
| primary_location.license | |
| primary_location.pdf_url | https://academic.oup.com/jimmunol/article-pdf/214/Supplement_1/vkaf283.1566/65410694/vkaf283.1566.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | The Journal of Immunology |
| primary_location.landing_page_url | https://doi.org/10.1093/jimmun/vkaf283.1566 |
| publication_date | 2025-11-01 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.- | 82 |
| abstract_inverted_index.a | 8, 63 |
| abstract_inverted_index.1) | 159 |
| abstract_inverted_index.2) | 178 |
| abstract_inverted_index.By | 197 |
| abstract_inverted_index.To | 53 |
| abstract_inverted_index.We | 153 |
| abstract_inverted_index.be | 101 |
| abstract_inverted_index.by | 218 |
| abstract_inverted_index.do | 143 |
| abstract_inverted_index.in | 93, 118, 138, 164 |
| abstract_inverted_index.is | 7, 25, 30, 91, 151, 188 |
| abstract_inverted_index.it | 96 |
| abstract_inverted_index.of | 23, 35, 43, 106, 161, 192 |
| abstract_inverted_index.on | 194 |
| abstract_inverted_index.or | 212 |
| abstract_inverted_index.to | 32, 59, 100, 171, 207, 210 |
| abstract_inverted_index.we | 61, 205 |
| abstract_inverted_index.BBB | 90 |
| abstract_inverted_index.CAR | 134 |
| abstract_inverted_index.R01 | 220 |
| abstract_inverted_index.The | 21 |
| abstract_inverted_index.all | 76 |
| abstract_inverted_index.and | 40, 46, 75, 122, 177, 228 |
| abstract_inverted_index.are | 154 |
| abstract_inverted_index.but | 29, 142 |
| abstract_inverted_index.how | 55, 199 |
| abstract_inverted_index.not | 26, 98, 144 |
| abstract_inverted_index.our | 94 |
| abstract_inverted_index.the | 36, 50, 72, 89, 102, 119, 127, 139, 147, 156, 165, 172, 183, 186, 203 |
| abstract_inverted_index.via | 190 |
| abstract_inverted_index.– | 79 |
| abstract_inverted_index.CD19 | 65 |
| abstract_inverted_index.also | 136 |
| abstract_inverted_index.does | 97 |
| abstract_inverted_index.down | 125 |
| abstract_inverted_index.hope | 206 |
| abstract_inverted_index.into | 49, 126, 146, 182 |
| abstract_inverted_index.site | 105 |
| abstract_inverted_index.that | 70, 113 |
| abstract_inverted_index.then | 123 |
| abstract_inverted_index.well | 27 |
| abstract_inverted_index.with | 12, 84 |
| abstract_inverted_index.(BBB) | 39 |
| abstract_inverted_index.CAR19 | 47, 56, 85, 107, 114, 162, 200 |
| abstract_inverted_index.ICANS | 24, 81 |
| abstract_inverted_index.Topic | 222 |
| abstract_inverted_index.Tumor | 224 |
| abstract_inverted_index.blunt | 211 |
| abstract_inverted_index.brain | 51 |
| abstract_inverted_index.cells | 48, 115, 163, 201 |
| abstract_inverted_index.enter | 202 |
| abstract_inverted_index.entry | 42, 104 |
| abstract_inverted_index.first | 116 |
| abstract_inverted_index.hCD19 | 193 |
| abstract_inverted_index.human | 13, 64 |
| abstract_inverted_index.leads | 58 |
| abstract_inverted_index.major | 103 |
| abstract_inverted_index.model | 69 |
| abstract_inverted_index.mouse | 68 |
| abstract_inverted_index.mural | 195 |
| abstract_inverted_index.space | 121, 141, 167 |
| abstract_inverted_index.that: | 158 |
| abstract_inverted_index.their | 169, 179 |
| abstract_inverted_index.(SLYM) | 176 |
| abstract_inverted_index.(TIPT) | 230 |
| abstract_inverted_index.ICANS, | 60 |
| abstract_inverted_index.ICANS. | 214 |
| abstract_inverted_index.Immune | 2 |
| abstract_inverted_index.T-cell | 18 |
| abstract_inverted_index.appear | 99 |
| abstract_inverted_index.brain, | 204 |
| abstract_inverted_index.cells. | 108, 196 |
| abstract_inverted_index.common | 9 |
| abstract_inverted_index.driven | 189 |
| abstract_inverted_index.model, | 95 |
| abstract_inverted_index.(CAR19) | 19 |
| abstract_inverted_index.(ICANS) | 6 |
| abstract_inverted_index.Funding | 215 |
| abstract_inverted_index.NIH/NCI | 219 |
| abstract_inverted_index.Rather, | 109 |
| abstract_inverted_index.Sources | 216 |
| abstract_inverted_index.T-cells | 135 |
| abstract_inverted_index.antigen | 16 |
| abstract_inverted_index.barrier | 38 |
| abstract_inverted_index.control | 133 |
| abstract_inverted_index.develop | 208 |
| abstract_inverted_index.involve | 33 |
| abstract_inverted_index.migrate | 124, 145 |
| abstract_inverted_index.prevent | 213 |
| abstract_inverted_index.reveals | 112 |
| abstract_inverted_index.spaces. | 131 |
| abstract_inverted_index.testing | 155 |
| abstract_inverted_index.therapy | 57 |
| abstract_inverted_index.thought | 31 |
| abstract_inverted_index.through | 129, 185 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Although | 88 |
| abstract_inverted_index.CA263090 | 221 |
| abstract_inverted_index.chimeric | 15 |
| abstract_inverted_index.clinical | 86 |
| abstract_inverted_index.efficacy | 74 |
| abstract_inverted_index.etiology | 22 |
| abstract_inverted_index.membrane | 175 |
| abstract_inverted_index.receptor | 17 |
| abstract_inverted_index.reflects | 168 |
| abstract_inverted_index.reported | 77 |
| abstract_inverted_index.syndrome | 5 |
| abstract_inverted_index.therapy. | 87 |
| abstract_inverted_index.(hCD19Tg) | 67 |
| abstract_inverted_index.Supported | 217 |
| abstract_inverted_index.Treatment | 229 |
| abstract_inverted_index.breakdown | 34 |
| abstract_inverted_index.cytokines | 45 |
| abstract_inverted_index.developed | 62 |
| abstract_inverted_index.including | 80 |
| abstract_inverted_index.migration | 181 |
| abstract_inverted_index.morbidity | 10 |
| abstract_inverted_index.Categories | 223 |
| abstract_inverted_index.accumulate | 117, 137 |
| abstract_inverted_index.anti-tumor | 73 |
| abstract_inverted_index.associated | 11, 83 |
| abstract_inverted_index.hypotheses | 157 |
| abstract_inverted_index.microscopy | 111 |
| abstract_inverted_index.parenchyma | 128, 184 |
| abstract_inverted_index.replicates | 71 |
| abstract_inverted_index.strategies | 209 |
| abstract_inverted_index.subsequent | 41, 180 |
| abstract_inverted_index.suggesting | 149 |
| abstract_inverted_index.toxicities | 78 |
| abstract_inverted_index.transgenic | 66 |
| abstract_inverted_index.two-photon | 110 |
| abstract_inverted_index.understand | 54 |
| abstract_inverted_index.understood | 28 |
| abstract_inverted_index.Co-injected | 132 |
| abstract_inverted_index.Description | 1 |
| abstract_inverted_index.Immunology: | 225 |
| abstract_inverted_index.Prevention, | 227 |
| abstract_inverted_index.blood-brain | 37 |
| abstract_inverted_index.compromised | 92 |
| abstract_inverted_index.parenchyma, | 148 |
| abstract_inverted_index.parenchyma. | 52 |
| abstract_inverted_index.recognition | 191 |
| abstract_inverted_index.trafficking | 150 |
| abstract_inverted_index.Checkpoints, | 226 |
| abstract_inverted_index.accumulation | 160 |
| abstract_inverted_index.localization | 170 |
| abstract_inverted_index.perivascular | 130 |
| abstract_inverted_index.subarachnoid | 120, 140, 166, 173 |
| abstract_inverted_index.CD19-specific | 14 |
| abstract_inverted_index.neurotoxicity | 4 |
| abstract_inverted_index.understanding | 198 |
| abstract_inverted_index.immunotherapy. | 20 |
| abstract_inverted_index.lymphatic-like | 174 |
| abstract_inverted_index.cell-associated | 3 |
| abstract_inverted_index.perivasculature | 187 |
| abstract_inverted_index.proinflammatory | 44 |
| abstract_inverted_index.antigen-specific. | 152 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| citation_normalized_percentile |